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Objectives: To examine the association between
overactive bladder (OAB) symptom severity and falls
and the contribution of OAB symptoms to falls in a
community-dwelling population.
Design: Cross-sectional study.
Setting: 2 Japanese municipalities.
Participants: A total of 2505 residents aged over
40 years, who participated in health check-ups
conducted in 2010. OAB symptom assessed via
overactive bladder symptom score (OABSS) was
divided into six categories based on distribution and
Japanese clinical guidelines. Mobility problems and
depressive symptoms were assessed via the Timed
Up and Go test and the short form of the Center for
Epidemiologic Studies Depression Scale, respectively.
Primary outcome measures: Self-reported any fall
and frequent fall (≥2) over the 1-month period.
Independent contributions to any fall and frequent falls
were assessed via logistic regression to generate
population-attributable fractions (PAFs), assuming
separate causal relationships between OAB symptoms,
mobility problems and depressive symptoms and any
or frequent falls.
Results: Among the total 1350 participants (mean
age: 68.3 years) analysed, any fall and frequent falls
were reported by 12.7% and 4.4%, respectively.
Compared with no OABSS score, moderate-to-severe
OAB and mild OAB were associated with any fall
(adjusted ORs 2.37 (95% CI 1.12 to 4.98) and 2.51
(95% CI 1.14 to 5.52), respectively). Moderate-to-
severe OAB was also strongly associated with frequent
falls (adjusted OR 6.90 (95% CI 1.50 to 31.6)).
Adjusted PAFs of OAB symptoms were 40.7% (95% CI
0.7% to 64.6%) for any fall and 67.7% (95% CI
−23.1% to 91.5%) for frequent falls. Further, these
point estimates were similar to or larger than those of
mobility problems and depressive symptoms.
Conclusions: An association does indeed exist
between OAB symptom severity and falls, and OAB
symptoms might be important contributors to falls
among community-dwelling adults. Further longitudinal
studies are warranted to examine whether or not OAB
symptoms predict risk of future falls and fall-related
injuries.
INTRODUCTION
Overactive bladder (OAB) is a urological
syndrome representing a common public
ARTICLE SUMMARY
Article focus
▪ An association has been reported between the
mere presence of overactive bladder (OAB) and
fall-related injuries in a US telephone-based
survey study.
▪ Whether or not the severity of OAB symptoms is
related to an increased likelihood of having falls in
community-dwelling individuals and how much the
OAB symptom impacts on falls remains unclear.
▪ We assessed the relationship between OAB
symptom severity and falls and estimated the poten-
tial contribution of OAB symptoms on falls among
community-dwelling individuals, assuming a causal
relationship between OAB symptoms and falls.
Key messages
▪ OAB was associated with both any fall and fre-
quent (≥2) falls over the 1-month study period
in community-dwelling adults.
▪ An increasing trend was noted between OAB
symptom severity and frequent falls over the
1-month period.
▪ Estimates of adjusted population-attributable
fraction of OAB symptoms on falls were similar
or larger than those of mobility problems and
depressive symptoms.
Strengths and limitations of this study
▪ Strengths of our study include large sample size,
population-based format, adjustment for many
potential confounding factors and the robustness
of the relationship between OAB symptom sever-
ity and falls based on sensitivity analyses.
▪ However, the following limitations should be
considered: the cross-sectional design cannot
attribute causality based solely on associations
between OAB symptom and falls and the assess-
ment of OAB symptoms based on self-reported
questionnaire cannot exclude the presence of
other urological disorders.
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health problem worldwide; the overall prevalence of
OAB in adults aged over 40 years was reported to be
12.4% in Japan and 16.6% in European countries, with
incidence increasing with age.1 2 OAB is characterised
by a primary symptom of urgency, with or without
incontinence, usually accompanied by nocturia and
increased frequency,3 although OAB can be diagnosed
even without reports of incontinence or nocturia.
Separately, falls are also a serious public health
problem, with one-third of community-dwelling indivi-
duals aged over 65 years falling at least once annually4
and with 5–10% of falls resulting in fracture, head
injuries or other serious injuries.5 While studies exam-
ining incontinence as a risk factor for falls have been
well investigated,6 7 few have examined the relationship
between OAB and falls, despite reported overlaps in
symptoms between incontinence and OAB.8
While ﬁndings from one US telephone survey sug-
gested an association between OAB and an increased
likelihood of being injured in a fall in the previous year
among adults aged over 18 years,9 whether or not the
degree of OAB symptom severity is related to the fre-
quency of falls among community-dwelling older adults
over a certain period of time is unclear. This previous
study also failed to examine the extent to which OAB
symptoms contribute to falls. Clariﬁcation of this poten-
tial inﬂuence of OAB symptom severity on falls may help
health policy-makers decide how much attention OAB
symptoms should receive to prevent falls among
community-dwelling individuals.
Here, we investigated the relationship between OAB
symptom severity and frequency of falls over a
1-month period using data from a large
community-dwelling population. We also assessed the
potential contribution of OAB symptom severity to
falls in the population.
METHOD
Our cross-sectional study of the locomotive syndrome
and health outcome in Aizu cohort study (LOHAS)—
which aims to evaluate the risk of cardiovascular
disease, quality of life, medical costs and mortality
attributable to locomotive dysfunction10—was
approved by the Research Ethics Committee of
Fukushima Medical University School of Medicine.
Locomotive syndrome is conceptualised as a condition
characterised by a set of associated symptoms due to
problems of the locomotive systems.11 The locations
involved are located in valleys surrounded by moun-
tains, and the main industry in the region is agricul-
ture. Our target population comprised the general
population of two communities (Tadami and
Minamiaizu Towns) in Fukushima Prefecture, Japan.
Eligibility criteria were ‘aged over 40 years’ and ‘parti-
cipated in annual health check-ups conducted in
2010’.10 Details of the design of the LOHAS have
been reported previously.10
OAB symptoms, mobility problems and depressive
symptoms
OAB symptoms were the main exposure and assessed
based on the OAB Symptom Score (OABSS),12 which is
designed to quantify OAB symptoms over the previous
week based on four items: daytime frequency, night-
time frequency, urgency and urgency incontinence (see
online supplementary table S1). The OABSS has been
psychometrically validated and has demonstrated reli-
ability, discriminant validity and responsiveness among
patients with OAB.12 13 Able to be used as an alterna-
tive to a bladder diary,14 which is considered the gold
standard tool for the assessment of OAB symptoms, the
OABSS is recommended in Japanese clinical practice.15
A total OABSS score of 3 or more and an urgency
score of 2 or more is the recommended cut-off for
diagnosing OAB, and the severity is further divided
into mild (total score of 3–5 points), moderate (6–11
points) and severe (12 or more points), according to
Japanese clinical practice guidelines.15 Therefore, indi-
viduals with a total OABSS score of 2 or less or an
urgency score of 1 or less are considered to be
‘non-OAB’. To assess the dose–response relationship of
the strength of the association between OAB symptom
severity and falls citing non-OAB individuals with a total
score of 0 as reference, participants with and without
OAB were divided into six categories based on the
severity of total OABSS score and the distribution of
the participants: non-OAB with 0, 1, 2 or 3 or more
points; mild OAB; and moderate-to-severe OAB. The
median and range of total OABSS score among the six
groups are described in table 1, along with the number
of participants.
In addition to accounting for the contribution of
OAB symptoms to falls, we considered the contribu-
tions of mobility problems (ie, problems in gait,
balance and mobility) and depressive symptoms as well,
citing these parameters as secondary exposures in light
of their prevalence in ageing societies and their pre-
dictability of fall risk in the literature.6 16 17 Mobility
problems were assessed using the Timed Up and Go
(TUG) test, in which the individuals are timed with a
stopwatch when rising from a chair, walking 3 m and
turning to return to sit on the chair. The TUG test is
considered to be a reﬂection of function in gait,
balance and mobility17 and is commonly used among
older persons in geriatric clinics to evaluate physical
performance,18 with a greater score indicating more
mobility problems. Given the ﬁndings from a
meta-analysis suggesting that reference TUG values
differ by age group (mean=8.1 s for 60 to 69, 9.2 s for
70 to 79 and 11.3 s for 80 to 99-year-olds),19 specifying
a uniform cut-off of TUG value to discriminate the
presence of mobility problems was difﬁcult, and the
TUG value was therefore treated as a continuous vari-
able. Although no reference TUG values have been
established for persons aged 40–59 years, we believe
that ‘5.5–8.1 s’ is a feasible range, as a previous study
2 Kurita N, Yamazaki S, Fukumori N, et al. BMJ Open 2013;3:e002413. doi:10.1136/bmjopen-2012-002413
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found the mean TUG value to be 5.5 s in healthy
young adults (mean age: 22.3 years) the mean TUG
value in adults aged 60-69 years was 8.1 s as described
above.20
Depressive symptoms were assessed using the 10-item
version of the Center for Epidemiological Studies
Depression Screening Index (CES-D), which is designed
to quantify the number and frequency of symptoms of
depression. Depressive mood was deﬁned as a score of
10 or greater.21
Clinical outcomes
We examined two clinical outcomes of interest—‘any fall
over a 1-month period’ and ‘frequent (≥2) falls over a
1-month period’—based on subjects’ answers to the ques-
tion, ‘Over the past year, have you fallen down?’ to estab-
lish fall history. Participants who responded, ‘Yes’, were
then asked the follow-up question, ‘How many times have
you fallen down over the past month?’ with responses of
‘zero’, ‘once’, ‘twice’ or ‘three or more times’ allowed.
Those who reported at least ‘once’ were considered to
have had ‘any fall’ over the previous month. Those who
reported at least ‘twice’ (≥2) were, in addition to ‘any
fall’, further considered to have had ‘frequent falls’.
Measurement of potential confounding variables
Potential confounding variables examined in the
present study were sociodemographic characteristics
including age, gender, exercise habit and living arrange-
ment (alone or cohabitating), as well as the presence of
cerebrovascular disease, all obtained via self-reported
questionnaire; body mass index and blood pressure, as
measured by local nurse practitioners; hypertension,
deﬁned as systolic blood pressure ≥140 mm Hg and dia-
stolic blood pressure ≥90 mm Hg or by individuals
reporting attending a physician for treatment; and dia-
betes, deﬁned as having glycosylated haemoglobin
values ≥6.1%, as described by the Japanese Diabetes
Society (equivalent to ≥6.5% described in National
Glycohemoglobin Standardization Program (NGSP)
values22) or by individuals reporting attending a phys-
ician for treatment. Individuals were considered to
engage in exercise if they answered ‘Yes’ to the question
concerning whether or not they had participated in
moderate physical activity (making the individual
breathe somewhat harder than normal and including
situations such as carrying light loads, bicycling at a
regular pace or doubles tennis) in the previous 7 days.
Statistical analysis
Participants with complete data were entered into the
primary analyses. Statistical analyses were conducted
using Stata V.11.0 (Stata Corp., College Station, Texas,
USA). Sociodemographic characteristics, comorbidities,
main (OAB symptom severity) and secondary exposures
(TUG values and depressive symptoms) and outcomes
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Effect measures in the present study were ORs of the
three exposures for any fall and frequent falls estimated
using logistic regression models, with separate models
applied for any fall and frequent falls over the previous
month. To estimate adjusted ORs, the potential con-
founding variables described above were simultaneously
forced into the models along with the three exposures.
The goodness of ﬁt of the models was assessed using the
Hosmer-Lemeshow test.
The potential effect modiﬁcation of gender differ-
ence, TUG and depressive symptoms on the association
between OAB symptom severity and any fall or frequent
falls over the previous month was tested by adding three
interaction pairs (the product terms of OAB symptoms
severity with gender, TUG or depressive symptoms) to
the logistic regression models.
In addition, using the regression models based on a
previously reported method, a test of linear trends
across six OAB symptom severity categories was per-
formed by treating the categories as a continuous vari-
able using their median values.23 To estimate the
potential contribution of each of the exposures (OAB
symptom severity, mobility problems or depression symp-
toms) to falls, we computed population-attributable frac-
tions (PAFs). In general, in a cross-sectional study, PAF is
the fraction of the prevalent outcomes that would be
prevented if a certain exposure was removed. In other
words, if the exposure was removed, then some fraction
of the outcomes could be prevented, and that fraction is
PAF. For this study, outcomes used were both ‘any fall’
and ‘frequent falls’, and exposures used were OAB
symptom severity, mobility problems and depression
symptoms. One assumption of this computation is that
there is an unconfounded, causal relation between
exposure(s) and outcome(s). PAFs were computed with
the logistic regression models and the user-written
command ‘punaf’ in Stata V.11.0.24 25
We also conducted sensitivity analyses by imputing
missing covariate values. A multiple imputation approach
using a chained equations method was used,26 27 with
results showing that 1037 participants (41.9%) had
missing covariate values. p<0.05 was considered statistic-
ally signiﬁcant.
RESULTS
Of the 2505 participants in the health check-up
(ﬁgure 1), 2387 (95.3%) had both exposure and
outcome variables. After excluding 1037 participants
with at least one confounding variables missing, the
remaining 1350 participants were ultimately entered
into the primary analyses.
Baseline characteristics are presented in table 1.
Participants tended to be older, with 85.5% aged over
60 years. The prevalence of hypertension and diabetes
were 65.1% and 10.0%, respectively. The prevalence of
OAB which met the criteria described in the Japanese
clinical guidelines was 20.0%, with prevalence of
moderate-to-severe OAB at 11.6%. Of note, the preva-
lence of non-OAB individuals with ≥3 points was 18.3%.
Age-stratiﬁed prevalence of OAB in our participants was
9.7% for 40 to 59, 14.7% for 60 to 69, 27.0% for 70 to
79 and 26.6% for 80 to 89-year-olds, values similar to
those noted in a previous study in Japan.2 Mean TUG
time in the present study was 7.5 s (SD 2.1 s), ranging
from a minimum of 3.9 s to a maximum of 26.1 s.
Age-stratiﬁed mean TUG values were 6.4 s for 40 to 59,
6.8 s for 60 to 69, 8.2 s for 70 to 79 and 9.8 s for 80 to
89-year-olds, values which were smaller than the
reported reference.19 The prevalence of depressive
symptoms was 15.5%. The prevalence of any fall and fre-
quent falls over the previous month was 12.7% and
4.4%, respectively, while age-stratiﬁed prevalence of any
fall and frequent falls over the previous month were
8.2% and 2.0% for 40 to 59, 11.0% and 3.3% for 60 to
69, 14.7% and 5.6% for 70 to 79, and 19.0% and 8.9%
for 80 to 89-year-olds, respectively.
Sociodemographic characteristics were similar
between participants with and without missing con-
founding variables (see online supplementary table S2)
Figure 1 Flow chart of the study
participants.
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except for gender, as men were more likely to have
missing variables. As a group, their OAB symptom sever-
ity, TUG value, proportion with depressive symptoms
and proportions of any and frequent falls over the
1-month period examined were similar.
In crude analyses, the presence of OAB, increase in
TUG, and the presence of depressive symptom indicated
a greater likelihood of having both any and frequent
falls (table 2), and ORs for these parameters were atte-
nuated in adjusted analyses. Participants with
moderate-to-severe OAB had a greater likelihood of
having any fall and frequent fall than non-OAB indivi-
duals with 0 points (adjusted OR for any fall=2.37 (95%
CI 1.12 to 4.98); and adjusted OR for frequent fall=6.90
(95% CI 1.50 to 31.6)). In addition, those with mild
OAB and non-OAB individuals with ≥3 points had a
similarly greater likelihood of having any fall (adjusted
OR 2.51 (95% CI 1.14 to 5.52), and adjusted OR=2.46
(95% CI 1.23 to 4.92), respectively) than non-OAB indi-
viduals with 0 points. We noted no signiﬁcant trends in
likelihood of any fall across OAB severity categories
(p=0.062), presumably because of similar strength of
likelihoods among the top three categories of OAB
severity. In contrast, we noted a signiﬁcant increasing
trend in the likelihood of frequent fall across OAB sever-
ity categories (p=0.015).
The adjusted ORs of TUG for any and frequent falls
were 1.25 (95% CI 1.06 to 1.47) and 1.36 (95% CI 1.09
to 1.70), respectively, for each increase in SD of TUG,
suggesting that the increase in TUG was associated with
these outcomes. The adjusted ORs of depression for any
and frequent falls were 1.96 (95% CI 1.31 to 2.94) and
1.98 (95% CI 1.06 to 3.71), respectively. The
goodness-of-ﬁt values of the covariate-adjusted logistic
regression models for any fall and frequent falls were
0.217 and 0.364, respectively.
Overall, effect modiﬁcation by gender difference,
TUG and depressive symptoms on the association
between the OAB severity and any fall or frequent falls
was not apparent (data not shown). Therefore, PAF ana-
lyses and sensitivity analyses were performed without
considering the effect modiﬁcation. Analyses results
indicated that, if OAB symptoms could have been
reduced to OABSS 0 points (with all other parameters
remaining the same), a sizeable proportion of any and
frequent falls could have been prevented potentially
(40.7% (95% CI 0.7% to 64.6%) and 67.7% (95% CI
−23.1% to 91.5%), respectively), although of note—the
lower CI of the proportion for frequent falls was already
below 0% (table 3). Similarly, if TUG could have been
improved up to 4 s (the second smallest value in this
population), the estimated proportions of the any and
frequent falls that could potentially have been prevented
were 30.4% (95% CI 7.6% to 47.6%) and 45.8% (95%
CI 13.1% to 66.2%), respectively. As for depressive symp-
toms, these estimated proportions were smaller, at 11.7%
(95% CI 3.8% to 18.9%) and 15.3% (95% CI −1.3% to
29.1%) for any and frequent falls, respectively.
Table 2 Associations between OAB symptom severity, mobility problems and depressive symptoms and falls
Number of
participants
Any fall over the previous month














193 1 1 1 1
Non-OAB with 1
point
360 1.68 (0.85 to 3.30) 1.61 (0.81 to 3.21) 3.29 (0.73 to 14.9) 2.97 (0.65 to 13.6)
Non-OAB with 2
points
280 1.74 (0.87 to 3.51) 1.46 (0.71 to 2.99) 3.17 (0.68 to 14.8) 2.17 (0.45 to 10.4)
Non-OAB with ≥3
points
247 3.18 (1.63 to 6.22) 2.46 (1.23 to 4.92) 4.88 (1.08 to 22.1) 3.35 (0.72 to 15.6)
Mild OAB 114 3.21 (1.50 to 6.85) 2.51 (1.14 to 5.52) 6.25 (1.28 to 30.6) 4.30 (0.84 to 22.0)
Moderate-to-severe
OAB
156 3.74 (1.85 to 7.56) 2.37 (1.12 to 4.98) 12.5 (2.84 to 54.6) 6.90 (1.50 to 31.6)
Trend p=0.018 Trend p=0.062 Trend p=0.006 Trend p=0.015
Timed Up and Go
Per 1 s 1350 1.21 (1.13 to 1.29) 1.11 (1.03 to 1.20) 1.28 (1.17 to 1.39) 1.16 (1.04 to 1.29)
Per 1SD 1.49 (1.30 to 1.71) 1.25 (1.06 to 1.47) 1.67 (1.39 to 2.00) 1.36 (1.09 to 1.70)
Depressive symptoms
Absent 1141 1 1 1 1
Present 209 2.65 (1.83 to 3.84) 1.96 (1.31 to 2.94) 3.16 (1.82 to 5.48) 1.98 (1.06 to 3.71)
OAB, overactive bladder.
*Estimated from logistic regression models adjusted for age, gender, body mass index, exercise habit, living arrangement, hypertension,
cerebrovascular disease, diabetes and all variables in the table.
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In sensitivity analyses using multiply imputed data for
2387 participants, similar associations were noted between
OAB severity symptoms and increased ORs for both clinical
outcomes (see online supplementary table S3).
DISCUSSION
In this large, cross-sectional study of community-dwelling
adults, moderate-to-severe OAB and mild OAB were
both associated with any falls over the 1-month study
period. We also observed an increasing trend in OAB
symptom severity with frequent falls, and
moderate-to-severe OAB was strongly associated with fre-
quent falls. In addition, OAB symptoms were found to
likely experience similar or greater impact on falls than
mobility problems and depressive symptoms. These ﬁnd-
ings may encourage health policy-makers and physicians
to pay more attention to OAB symptoms than at present
to help prevent falls among community-dwelling adults.
Our ﬁndings here agree well with those of a previous
study, which showed that the presence of OAB increased
the likelihood of being injured from a fall in the previ-
ous year (OR 2.26).9 However, the present and previous
studies differed in several respects. First, the mean age
of the participants in our study was much higher than
that in the previous study (68.3 vs 54.2 years), suggesting
that our ﬁndings will be more applicable in ageing soci-
eties. Second, the previous study used matching to
compare subjects with and without OAB; as such, their
study design limited the accurate determination of
prevalence of OAB symptom severity and estimation of
PAF. Our use of PAF in the present study suggested the
potential magnitude of reduction in falls that could the-
oretically be prevented in an ageing society such as the
one examined here. PAF estimates of OAB symptoms in
societies such as that involved in the present study with
an unignorable proportion of falls would be of signiﬁ-
cant relevance to health policy-makers and physicians.
Third, the telephone-based survey method hampered
the determination of several biological measures in the
previous study, such as body mass index and mobility
problems (ie, TUG), which are potentially confounding
variables that should be considered in the accurate
assessment of the relationship between OAB and falls.
Fourth, the dose–response relationship between OAB
symptom severity and falls was not evaluated in the
previous study; therefore, we feel that the logical con-
nection between OAB and falls in the previous study is
less convincing than that in the present study.
Several strengths to the present study warrant
mention. First, we demonstrated the relationship
between OAB symptom severity and falls in a large,
community-dwelling population, adjusting for confound-
ing variables such as body mass index and depressive
symptoms, which are potentially related to both OAB
and falls. Second, we showed that the contribution of
OAB symptoms to falls might be similar or larger than
that of mobility problems and depressive symptoms,
according to PAF estimates. These ﬁndings provide a
basis for considering the effective use of limited medical
resources to prevent falls. Noted similarities in the rela-
tionship of OAB symptom severity and falls in our sensi-
tivity analyses indicate that our results are robust.
However, several limitations to the present study also
warrant mention. First, we were unable to include the
medication usage and all chronic conditions in our ana-
lyses; given that use of antihypertensives or sedatives are
also potential risk factors for falls, the association
between OAB symptom severity and falls in the present
study might be confounded by these factors. To mitigate
this limitation, we adjusted for individuals with hyperten-
sive problems. Effects of depressive symptoms on falls
might be mediated partly by sedatives, as individuals
with depressive symptoms are often prescribed sedatives
to treat depressive emotion or sleep problems. However,
we believe it unlikely that effects of OAB on falls are
confounded by sedatives. While some specialists may
express concern about whether or not antimuscarinics
for OAB are associated with an elevated risk of falls
among treated individuals, to date, little evidence has
been generated which supports such an association.28
Cognitive impairment and arthritis (including osteoarth-
ritis) are also potential risk factors for falls29 30; however,
individuals with cognitive impairment are unlikely to
participate in epidemiological studies and complete self-
reported questionnaires.31 Regarding arthritis in particu-
lar, its burden on functional mobility should be reﬂected
by TUG. As such, we believe that these confounding
factors had negligible effects on our analyses. Second,
given that the deﬁnition of OAB in this study used
the criteria deﬁned by the Japanese Urological
Associations,15 the presence of other urological
Table 3 Population-attributable fraction for falls*
Any fall over the previous month Frequent (≥2) falls over the previous month
Estimates (95% CI) Estimates (95% CI)
OAB symptom 40.7% (0.7% to 64.6%) 67.7% (−23.1% to 91.5%)
Timed Up and Go† 30.4% (7.6% to 47.6%) 45.8% (13.1% to 66.2%)
Depressive symptoms 11.7% (3.8% to 18.9%) 15.3% (−1.3% to 29.1%)
OAB, overactive bladder; TUG, Timed Up and Go.
*Estimated from logistic regression models adjusted for age, gender, body mass index, exercise habit, living arrangement, hypertension,
cerebrovascular disease, diabetes and all the variables in the table.
†Estimated assuming that all participants have TUG value of 4 s, the second smallest value in this population.
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disorders (such as benign prostatic enlargement and
urinary tract infection) cannot be ruled out. Third, the
cross-sectional design of the present study means that we
cannot attribute causality from the associations between
any exposures and falls. While we believe that OAB
being a cause of falling is possible and biologically plaus-
ible, some associations such as those between depressive
symptoms and falls can be explained by reverse causality.
Fourth, although sensitivity analyses using 95.2% of the
participants in the health check-up exam showed an
association similar to that noted in primary analyses
between OAB symptom severity and falls, a high rate of
missing data was noted in the primary analyses. Fifth,
PAF of OAB symptom for frequent falls had low
precision, although its point estimate suggested that a
sizeable proportion of frequent falls might be prevent-
able. Further, we were unable to estimate PAFs in the
sensitivity analysis because, at present, statistical analyses
are difﬁcult to conduct using multiply imputed data.
However, distributions of OAB symptom severity, TUG
and depressive symptoms are similar between individuals
with complete data and those with missing covariates.
Therefore, it is unlikely that PAF estimates in the com-
plete dataset would be starkly different from those in
the target population.
We feel that the present ﬁndings will inﬂuence the
activities of physicians and health policy-makers for
several reasons. First, OAB symptoms are potentially
modiﬁable risk factors for falls, able to be managed with
a combination of behavioural therapy and antimuscari-
nics indicated for OAB. Indeed, well-designed clinical
trials have shown that antimuscarinics such as solifenacin
and tolterodine reduce the severity of OAB symptoms
by more than 60%.15 A further study is needed to clarify
whether or not the treatment of OAB symptoms is
associated with the reduction of falls. However,
community-dwelling individuals may hesitate to consult
physicians regarding OAB symptoms, in light of poten-
tial stigma attached to the disorder.9 As such, when phy-
sicians encounter patients who have suffered falls, they
should be sensitive when asking patients about their
experiencing any OAB symptoms. This communication
is applicable to both genders, as no gender differences
were apparent in the relationship between OAB symp-
toms and falls. Second, the dose-response relationship
between OAB symptom severity and frequent falls sug-
gests that not only nocturia and incontinence but also
urgency and frequency may contribute to the risk of fall.
While previous fall-related studies have thus far focused
primarily on nocturia and incontinence,6 32 more fre-
quent walking to the bathroom may raise the risk of
falling. In addition, urgency may cause individuals to
lose focus while walking due to nocturia or frequency,
rendering them to be more susceptible to falling. Third,
given the large PAF values for OAB symptoms for falls in
our study, health policy-makers and physicians should
consider OAB to be not only a mere syndrome reducing
the health-related quality of life but also a large
contributor to falls among community-dwelling indivi-
duals. As such, screening for OAB at health check-ups
and appropriate referral may be a reasonable health
plan to interact. We should also point out that physicians
caring for fall victims and those treating OAB patients
are usually different and may therefore not be commu-
nicating well. Compared with these physicians, primary
care physicians and their team may provide better and
care for the symptoms of the individuals.
In conclusion, OAB symptom severity in community-
dwelling adults was found to be associated with any and fre-
quent falls over a 1-month period. Further, OAB symptoms
might have a similar or greater contribution to falls than
mobility problems or depressive symptoms, both common
in ageing societies. Further longitudinal studies are war-
ranted to examine whether or not OAB symptoms predict
future falls and fall-related injuries.
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